EnChannel Medical

Healthcare SpecialistsSeries BGuangzhou, Chinaenchannel.com

Latest round

Series B

Last raised

May 2025

Total raised

$110M

Investors

3

About EnChannel Medical

Established in 2020 and based in Guangzhou, China, EnChannel operates as a medical technology company that provides atrial fibrillation treatment solutions and related products. The company is headquartered in Guangzhou and has offices in United States and Shanghai. Jun Feng, the co-founder and CEO of the company, has 28 years of experience in the clinical and medical technology fields of medicine and worked at Medtronic and St. Jude, Inc. Min Zhu, the co-founder and CTO of the company, once served as the chief applied mathematician, director of Engineering of Algorithms at Acutus Medical.  The company engages in the research and development of atrial fibrillation therapy products using 3D labeling and PFA ablation technologies. Its products include NanoAblate™ pulsed field ablator, PFLine linear pulsed electric field ablation catheter, PFBasket shaped pulsed field ablation catheter and DePolar 4D cardiac labeling system, etc. Products can treat patients with paroxysmal atrial fibrillation and atrial flutter.

Who invested in EnChannel Medical

3 investors across 2 rounds

See all investors in EnChannel Medical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    May 1, 2025

    Amount

    $82M

    Investors

    Locked

  2. Series A

    Aug 1, 2023

    Amount

    $28M

    Investors

    Locked

Questions about EnChannel Medical

Who invested in EnChannel Medical?

EnChannel Medical has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has EnChannel Medical raised?

EnChannel Medical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did EnChannel Medical last raise money?

EnChannel Medical's most recent round on record is a Series B, in May 2025.

What does EnChannel Medical do?

Established in 2020 and based in Guangzhou, China, EnChannel operates as a medical technology company that provides atrial fibrillation treatment solutions and related products.

Where is EnChannel Medical headquartered?

EnChannel Medical is headquartered in Guangzhou, China.

Which VCs invest in companies like EnChannel Medical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at EnChannel Medical's stage. Their profiles are linked below.

Raising like EnChannel Medical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.